Related Experiment Video

Updated: Aug 6, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

Cell death and cancer therapy

F Bunz1

  • 1Radiation Biology Program, The Johns Hopkins Oncology Center, The Johns Hopkins School of Medicine, Baltimore, MD 21231, USA. bunzfre@welch.jhu.edu

Current Opinion in Pharmacology
|November 17, 2001
PubMed

Insights

Targeting cancer requires selectively killing tumor cells. Understanding cell death pathways, including p53 and Bcl-2 family proteins, offers new strategies against therapy-resistant cancers.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell death pathways

Background:

  • Effective cancer treatment necessitates selective elimination of malignant cells.
  • Key molecular components in cell death pathways, such as p53, Apaf-1, and Bcl-2 family proteins, are frequently altered in various cancers.
  • Dysregulation of these pathways contributes to therapeutic resistance.

Purpose of the Study:

  • To explore the role of identified molecular components in cell death pathways.
  • To investigate how understanding these pathways can inform strategies against treatment-resistant cancers.

Main Methods:

  • Literature review and analysis of recent findings in molecular biology and cancer research.
  • Identification and examination of key proteins involved in apoptosis (programmed cell death).

Main Results:

  • Several molecular players in cell death pathways (p53, Apaf-1, inhibitor of apoptosis proteins, Bcl-2 family) are implicated in cancer.
  • Alterations and disregulation of these components are common in cancerous cells.
  • Elucidation of these pathways provides insights into cancer biology.

Conclusions:

  • Recent advances in understanding cell death pathways are crucial for developing novel cancer therapies.
  • Targeting specific molecular components offers potential strategies to overcome therapeutic resistance in cancer.

More Related Videos

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy10:03

Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy

Published on: August 2, 2024

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...